Evidence map›Paper›PMID 20192995›Full record

ReviewImmunological reviews2010

CD4+CD25+ regulatory T cells in autoimmune arthritis.

Soyoung Oh, Andrew L Rankin, Andrew J Caton

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Th17 and Treg cells in bone related diseases.Clinical & developmental immunology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Soyoung OhThe Wistar Institute, Philadelphia, PA 19104, USA.
Andrew L Rankin
Andrew J Caton
The Wistar Institute · US

Funding

RECEPTOR DIVERSITY IN RECOGNITION OF INFLUENZA HAR01AI024541 · NIAID · WISTAR INSTITUTE · PI CATON, ANDREW J · 1987 to 2012
$4.6M
Specificity and Function of CD25+ Regulatory T CellsR01AI059166 · NIAID · WISTAR INSTITUTE · PI CATON, ANDREW J · 2004 to 2013
$3.9M
Regulatory T cell diversity in recognition of influenza virus HAR56AI024541 · NIAID · WISTAR INSTITUTE · PI CATON, ANDREW J · 2007 to 2016
$990k
NIAID NIH HHS AI24541NIAID NIH HHS AI59166NIAID NIH HHS R01 AI024541NIAID NIH HHS R01 AI059166NIAID NIH HHS R56 AI024541
6 · The paper itself

Abstract

CD4(+)CD25(+) regulatory T (Treg) cells can play a critical role in the prevention of autoimmunity, as evidenced by the cataclysmic autoimmune disease that develops in mice and humans lacking the key transcription factor forkhead box protein 3 (Foxp3). At present, however, how and whether Treg cells participate in the development of rheumatoid arthritis (RA), which has both systemic manifestations and a joint-targeted pathology that characterizes the disease, remains unclear. In this review, we describe work that has been carried out aimed at determining the role of Treg cells in disease development in RA patients and in mouse models of inflammatory arthritis. We also describe studies in a new model of spontaneous autoimmune arthritis (TS1 x HACII mice), in which disease is caused by CD4(+) T cells recognizing a neo-self-antigen expressed by systemically distributed antigen-presenting cells. We show that TS1 x HACII mice develop arthritis despite the presence of CD4(+)CD25(+)Foxp3(+) Treg cells that recognize this target autoantigen, and we outline steps in the development of arthritis at which Treg cells might potentially act, or fail to act, in the development of inflammatory arthritis.

Indexed as

AutoimmunityAnimalsArthritis, ExperimentalArthritis, RheumatoidAutoantigensAutoimmune DiseasesCytokinesForkhead Transcription FactorsHumansInflammation MediatorsInterleukin-2 Receptor alpha SubunitMiceMice, TransgenicSignal TransductionT-Lymphocytes, RegulatoryAutoantigensCytokinesForkhead Transcription FactorsFOXP3 protein, humanFoxp3 protein, mouseInflammation MediatorsInterleukin-2 Receptor alpha Subunit

Identifiers

PMID20192995
PMCPMC2908310
OpenAlexW2085601342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.